158 related articles for article (PubMed ID: 22248458)
1. Current concepts on pathogenesis and biology of metastatic osteosarcoma tumors.
Poletajew S; Fus L; Wasiutyński A
Ortop Traumatol Rehabil; 2011; 13(6):537-45. PubMed ID: 22248458
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
3. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner.
Fernández L; Valentín J; Zalacain M; Leung W; Patiño-García A; Pérez-Martínez A
Cancer Lett; 2015 Nov; 368(1):54-63. PubMed ID: 26276724
[TBL] [Abstract][Full Text] [Related]
4. The role of extracelluar matrix in osteosarcoma progression and metastasis.
Cui J; Dean D; Hornicek FJ; Chen Z; Duan Z
J Exp Clin Cancer Res; 2020 Sep; 39(1):178. PubMed ID: 32887645
[TBL] [Abstract][Full Text] [Related]
5. Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma.
Izadpanah S; Shabani P; Aghebati-Maleki A; Baghbanzadeh A; Fotouhi A; Bisadi A; Aghebati-Maleki L; Baradaran B
J Cell Physiol; 2020 May; 235(5):4167-4182. PubMed ID: 31709547
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways.
Zhang Y; Yang CQ; Gao Y; Wang C; Zhang CL; Zhou XH
Oncol Rep; 2014 Sep; 32(3):965-72. PubMed ID: 24969680
[TBL] [Abstract][Full Text] [Related]
9. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
10. Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.
Endo-Munoz L; Cai N; Cumming A; Macklin R; Merida de Long L; Topkas E; Mukhopadhyay P; Hill M; Saunders NA
PLoS One; 2015; 10(8):e0133592. PubMed ID: 26317203
[TBL] [Abstract][Full Text] [Related]
11. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
12. Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.
Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
[TBL] [Abstract][Full Text] [Related]
13. Effects of low-intensity pulsed ultrasound on osteosarcoma and cancer cells.
Sawai Y; Murata H; Koto K; Matsui T; Horie N; Ashihara E; Maekawa T; Fushiki S; Kubo T
Oncol Rep; 2012 Aug; 28(2):481-6. PubMed ID: 22614439
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach.
Bao Q; Gong L; Wang J; Wen J; Shen Y; Zhang W
Ann Surg Oncol; 2018 Sep; 25(9):2642-2651. PubMed ID: 29981024
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.
Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF
Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976
[TBL] [Abstract][Full Text] [Related]
16. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
[TBL] [Abstract][Full Text] [Related]
17. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma.
Rainusso N; Brawley VS; Ghazi A; Hicks MJ; Gottschalk S; Rosen JM; Ahmed N
Cancer Gene Ther; 2012 Mar; 19(3):212-7. PubMed ID: 22173710
[TBL] [Abstract][Full Text] [Related]
19. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.
Cersosimo F; Lonardi S; Bernardini G; Telfer B; Mandelli GE; Santucci A; Vermi W; Giurisato E
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
